Dorota Lebiedz-Odrobina
( out of 317 reviews )

Dorota Lebiedz-Odrobina, MD

Languages spoken: English, Polish, Russian

Clinical Locations

South Jordan Health Center

South Jordan
801-213-4500
Directions

Sugar House Health Center

Salt Lake City
801-581-2000
Directions

University of Utah Hospital

Rheumatology, Area E
Salt Lake City
801-581-7724
Directions

  • Dorota Lebiedz-Odrobina, MD is an Assistant Professor in the Division of Rheumatology, Department of Internal Medicine at the University of Utah and the Rheumatology Fellowship Program Director. She is a general clinical rheumatologist who sees patients with all forms of rheumatic disease. Her clinical and research interests include lung manifestations of rheumatic diseases and inflammatory myopathy, she is also ACR certified in musculoskeletal ultrasound.

    She received her medical degree at Jagiellonian University Medical College, Krakow, Poland. Dr. Odrobina completed her internal medicine residency at St. Joseph Hospital, Chicago, IL and a rheumatology fellowship at the University of Massachusetts Medical School, Worcester, MA. She practiced rheumatology in Southbridge, MA prior to joining the University of Utah School of Medicine in 2013.

    Dr. Odrobina is fluent in English and Polish.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Rheumatology)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 317 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 23, 2025
    SUGAR HOUSE HEALTH CENTER

    She's the best.

    January 23, 2025
    SUGAR HOUSE HEALTH CENTER

    Dr. Odrobina has been incredible! Getting an autoimmune diagnosis can be scary with all of the unknowns, but she is very knowledgeable and experienced, and constantly stays on it with all of the coordinated care that is needed. She is also very balanced and wants to make sure that I am not letting the diagnosis stop me from living my life. I appreciate her very much!

    January 20, 2025
    SUGAR HOUSE HEALTH CENTER

    She is my favorite doctor.

    January 16, 2025
    SUGAR HOUSE HEALTH CENTER

    She is very knowledgeable and truly caring. she finds answers to my questions.

    January 14, 2025
    SUGAR HOUSE HEALTH CENTER

    Listens to and deals with concerns.

    January 09, 2025
    SOUTH JORDAN HEALTH CENTER

    She listens and reacts to the comments from me and follows through.

    January 06, 2025
    SUGAR HOUSE HEALTH CENTER

    Dr. Odrobina, MD, is very helpful and not only asks questions of my concern but follows up with concise exploration and tests needed to make accurate help in my diagnosis.

    January 05, 2025
    SUGAR HOUSE HEALTH CENTER

    Dorota takes her time and really explains how to tackle a situation. She is a great provider who I would truly recommend to anyone.

    January 04, 2025
    SUGAR HOUSE HEALTH CENTER

    Intelligent, well informed, excellent with explanations and providing appropriate strategies for illnesses that are challenging and threatening.

  • Dorota Lebiedz-Odrobina, MD is an Assistant Professor in the Division of Rheumatology, Department of Internal Medicine at the University of Utah and the Rheumatology Fellowship Program Director. She is a general clinical rheumatologist who sees patients with all forms of rheumatic disease. Her clinical and research interests include lung manifestations of rheumatic diseases and inflammatory myopathy, she is also ACR certified in musculoskeletal ultrasound.

    She received her medical degree at Jagiellonian University Medical College, Krakow, Poland. Dr. Odrobina completed her internal medicine residency at St. Joseph Hospital, Chicago, IL and a rheumatology fellowship at the University of Massachusetts Medical School, Worcester, MA. She practiced rheumatology in Southbridge, MA prior to joining the University of Utah School of Medicine in 2013.

    Dr. Odrobina is fluent in English and Polish.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Rheumatology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Rheumatology)
    National Board of Medical Examiners

    Education history

    Post Graduate Training University of Utah MEHP
    Fellowship Rheumatology - University of Massachusetts Medical School Fellow
    Residency Internal Medicine - St. Joseph Hospital Resident
    Residency Internal Medicine - Ludwik Rydygier Hospital Resident
    Internship Medicine - Stefan Zeromski Hospital Intern
    Professional Medical Medicine - Jagiellonian University Medical College M.D.

    Selected Publications

    Journal Article

    1. Yu JM, VanBuren JM, Child A, Alvey JS, Mandl LA, Pinheiro LC, Assassi S, Bernstein EJ, Castelino FV, Chung L, Evnin L, Frech TM, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Gordon JK (2025). Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient Reported Outcome for Skin Disease in Patients with Systemic Sclerosis. J Rheumatol. (Read full article)
    2. Maharjan AS, Amjadi SS, Jaskowski TD, Laulu SL, Lebiedz-Odrobina D, Frech TM, Tebo AE (2024). Diagnostic performance of specific biomarkers for interstitial lung disease: a single center study. Clin Chem Lab Med. (Read full article)
    3. Nelson HA, Novis CL, Lebiedz-Odrobina D, Nandakumar V (2023). Performance of Anti-Carbamylated Protein Antibody Testing in the Routine Evaluation of Rheumatoid Arthritis from a Single Center. J Appl Lab Med, 9(2), 251-261. (Read full article)
    4. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy SL (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Front Neurol, 14, 1174116. (Read full article)
    5. Luebker S, Frech T, Assassi S, Skaug B, Gordon JK, Lakin K, Bernstein EJ, Luo Y, Steen VD, Shah AA, Hummers LK, Richardson C, Moore DF, Khanna D, Castelino FV, Chung L, Kapoor P, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Shah A, Makol A, Lebiedz-Odrobina D, Thomas JK, Volkmann ER, Molitor JA, Sandorfi N (2023). CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. Rheumatology (Oxford), 62(10), 3433-3438. (Read full article)
    6. Tebo AE, Peterson LK, Snyder MR, Lebiedz-Odrobina D (2023). Clinical Significance of Anti-U1 Ribonucleoprotein Antibody Is Analyte Dependent: Implications for Laboratory Reporting, Interpretation, and Interassay Correlations. Arch Pathol Lab Med. (Read full article)
    7. Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO, TRAIL1 Network Investigators (2022). Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med, 11(1), 87-96. (Read full article)
    8. Skemp-Dymond G, Lebiedz-Odrobina D, Zuromski LM, Rhoads JLW, Tebo AE (2021). Assessment of a Line Immunoassay for the Detection of Mi-2 Antibodies. Am J Clin Pathol, 157, 506-509. (Read full article)
    9. Overbury RS, Stoddard GJ, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (2021). The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle. BMC Health Serv Res, 21(1), 913. (Read full article)
    10. Frech T, McNeill C, Lebiedz-Odrobina D, Lewis G (2019). Amniotic membrane dressings: an effective therapy for SSc-related wounds. Rheumatology, 58(4), 734–736.
    11. Aggarwal R, Lebiedz-Odrobina D, Sinha A, Manadan A, Case JP (2009). Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies. J Rheumatol, 36(12), 2711-4. (Read full article)

    Review

    1. Lebiedz-Odrobina D, Kay J (2010). Rheumatic manifestations of diabetes mellitus. [Review]. Rheum Dis Clin North Am, 36(4), 681-99. (Read full article)

    Case Report

    1. Alhomida F, Beck DB, George TI, Shaffer A, Lebiedz-Odrobina D, Kovacsovics T, Madigan LM (2021). Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndrome. JAAD Case Rep, 14, 111-113. (Read full article)
    2. Kramer GD, Lebiedz-Odrobina D, Mamalis N (2017). Amyloidosis Mimicking Temporal Arteritis in Multiple Myeloma. Ophthalmology, 124(12), 1798. (Read full article)

    Abstract

    1. Ching C, Mulcaire-Jones E, Shaffer A, Gililland J, Battistone M, Lebiedz-Odrobina D (2022). Providers’ Adoption of 2017 Guidelines on DMARD Use Perioperatively for Elective Total Hip and Knee Arthroplasty at a Single Academic Center. [Abstract]. 74(suppl 9).
    2. Julie Thomas, Dorota Lebiedz-Odrobina, Kyle Register, Francesca Ferrara, Danielle Barlow, Alicia Riddle and Karla Miller (2020). Lessons Learned Through Rapid Quality Improvement for Telehealth Implementation in an Academic Rheumatology Practice During the COVID-19 Pandemic [Abstract].
    3. Rebecca Overbury, Jakrapun Pupaibool, Christopher Hansen and Dorota Lebiedz-Odrobina (2020). Hydroxychloroquine Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution [Abstract].
    4. Andrew Shaffer, Erica Mulcaire-Jones, Michael Battistone, Jeremy Gililland, Victor Carlson, Joshua Zimmerman, Kevin Lammert and Dorota Lebiedz-Odrobina (2020). Assessing Provider Knowledge and Opinions of the 2017 Guidelines for Perioperative Management of Antirheumatic Medications in a Single Academic Center. [Abstract]. 72(suppl 10).
    5. Quinn Pritchett, Rebecca Overbury, Dorota Lebiedz-Odrobina, Julie Thomas, Tawnie Braaten, Stacey Clardy, Marc Elgort, Emily Spivak, Patricia Slev, Lisa Peterson and Tracy Frech (2020). Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations [Abstract].
    6. Overbury R, Pupaibool J, Hansen C, Clegg D, Lebiedz-Odrobina D (2019). Hydroxychloroquine (HCQ) Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution [Abstract]. 71(suppl 10), 320.
    7. Amjadi S, Frech T, Chan J, Scholand M, Jaskowski T, Laulu S, Genzen J, Lebiedz-Odrobina D, Tebo A (2019). Use of Serum Lung Injury Biomarkers for Predicting the Severity of Interstitial Lung Disease in Patients with Connective Tissue Disease Associated Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features [Abstract]. 71(suppl 10), 370.
    8. Wong KGalli JBacharach RKlein JEsquibel LPace LLebiedz-Odrobina DRose JTrump BHull CGreenlee JClardy S (May 5, 2019). Neurologic Involvement in Seronegative Sjögren’s Syndrome with Positive Lip Biopsy: A Single Center Experience [Abstract]. 92(15 Supplement), P1.2-041.
    9. Wright J, Odrobina D, Scholand MB, Tebo AE, Frech TM (2018). Clinical Features and Timing of Studies in Interstitial Lung Disease with Autoimmune Disease Features: Do Autoantibody Panels Improve Diagnostic Yields and/or Increase Costs? [Abstract]. Arthritis Rheumatol, 70(suppl 10).
    10. Barker A, Beck JP, Cannon G, Grotzke M, Swasey S, Koening CL, Lebiedz-Odrobina D, Okuda Y, Battistone MJ (2017). Five-Year Evolution of the Center of Excellence in Musculoskeletal Care and Education: A National Resource for the Continuum of Health Professions Education and Scholarship [Abstract]. Arthritis Rheumatol, 69(suppl 10).